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The present study involves preparation and evaluation of floating
microspheres of verapamil hydrochloride for improving the drug
bioavailability by prolongation of gastric residence time. Cellulose
acetate, acrycoat S100 and eudragit S100 microspheres loaded
with verapamil hydrochloride were prepared by solvent diffusion-
evaporation method. The microspheres had smooth surfaces, with
free-flowing and good-packing properties. The yield of the
microspheres was up to 70.51% and cellulose acetate microspheres
entrapped the maximum amount of the drug. Scanning electron
microscopy confirmed their hollow structures with sizes in the range
251.80 to 350.75 μm. The prepared microspheres exhibited
prolonged drug release and remained buoyant for more than 12 h.
Radiographic images of dog stomach revealed that cellulose
acetate microspheres loaded with barium sulphate floated on the
gastric fluid for about 3.2 h. In vitro release studies demonstrated
non-Fickian diffusion of drug from the microspheres.
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INTRODUCTION
Oral delivery of drugs is by far the most preferable
route of drug delivery due to ease of administration, patient
compliance and flexibility in formulation etc. From
immediate release to site-specific delivery, oral dosage
forms have really progressed. However, it is a well-
accepted fact that it is difficult to predict the real in vivo
time of release with solid, oral controlled release dosage
forms. Thus, drug absorption in gastrointestinal (GI) tract
may be very short and highly variable in certain
circumstances (Garg, Sharma, 2003; Singh, Kim, 2000).
Several difficulties are faced in designing controlled
release systems for better absorption and enhanced
bioavailability. Various attempts have been made to
prolong the retention time of the dosage form in the
stomach. One such method is the preparation of a device
that remains buoyant in the stomach contents due to its
lower density than that of the gastric fluids (Desai, Bolton,
1993; Whitehead et al., 1998). Single-unit formulations are
associated with problems such as sticking together or being
obstructed in the gastrointestinal tract, which may have a
potential danger of producing irritation. On the other hand,
a floating system made of multiple unit forms has relative
merits compared to a single unit preparation. Indeed, the
gastric emptying of a multiparticulate floating system
would occur in consistent manner with small individual
variations. On each subsequent gastric emptying, sunk
particles will spread out over a large area of absorption
sites, increasing the opportunity for drug release profile and
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absorption in a more or less predictable way. Moreover,
since each dose consists of many subunits, the risk of dose
dumping is reduced (Iannuccelli et al., 1998; Kawashima
et al., 1992).
Verapamil hydrochloride, a calcium channel blocker
is widely used for the treatment of hypertension, angina
pectoris, supraventricular tachycardia and myocardial
infraction. It is completely absorbed (90%) from the
gastrointestinal tract after oral administration but has very
low bioavailability of 22±8%. The low bioavailability is
owing to the rapid biotransformation in the liver with a
biological half-life of 4.0±1.5 hours. The short biological
half-life and poor bioavailability of drug favours
development of sustained release formulation (Passerini et
al., 2003; Thummel et al., 2001).
The objective of the present work was to develop and
characterize floating microspheres of verapamil
hydrochloride, which after oral administration could
prolong the gastric residence time and increase the drug
bioavailability.
MATERIAL AND METHODS
Verapamil hydrochloride was received as a gift sample
from Nicholas Piramal (India) Ltd., Mumbai. Torrent
Pharmaceuticals Ltd., Ahmedabad, India provided Eudragit
S100. Cellulose Acetate was procured from Ottokemi,
Mumbai, India. Acrycoat S100 was purchased from Corel
Pharma. Chem., Ahmedabad, India. Polyvinyl alcohol,
hydrochloric acid and tween 80 were procured from Central
Drug House Ltd., Delhi, India. Dichloromethane, ethanol,
acetone, ethyl acetate and isopropyl alcohol were purchased
from E. Merck (India) Ltd., Mumbai. All the other chemicals
used were of analytical grade.
Preparation of floating microspheres
Floating microspheres loaded with verapamil
hydrochloride were prepared using solvent diffusion-
evaporation method (Soppimath et al., 2001) using
cellulose acetate (F1), eudragit S100 (F2) and acrycoat
S100 (F3). Drug and polymer in proportion of 1:2 were
dissolved in 1:1 mixture of solvent system of ethyl acetate
and acetone for cellulose acetate, dichloromethane and
ethanol for acrycoat S100; dichloromethane, ethanol and
isopropyl alcohol (1:1:1) for eudragit S100. This clear
solution was poured slowly in a thin stream into the
aqueous solution of 0.05% polyvinyl alcohol. The emulsion
was continuously stirred for 3 h at a speed of 500 rpm at
27±2°C. The floating microspheres were collected by
decantation, while the non-floating microspheres were
discarded. The microspheres were dried overnight at
40±2°C and stored in desiccator.
Size and shape of microspheres
The size of microspheres was determined using
microscope (Olympus NWF 10x, Educational Scientific
Stores, India) fitted with an ocular micrometer and stage
micrometer. Scanning electron microscopy (SEM) (Leo
430, Leo Electron Microscopy Ltd, Cambridge, England)
was performed to characterize the surface of the formed
microspheres. Microspheres were mounted directly onto
sample stub and coated with gold film (~200 nm) under
reduced pressure (0.133 Pa).
Flow properties
The flow properties of microspheres were characterized
in terms of angle of repose, carr index and hausner ratio (Sinha
et al., 2005). For determination of angle of repose (θ), the
microspheres were poured through the walls of a funnel, which
was fixed at a position such that its lower tip was at a height
of exactly 2.0 cm above hard surface. The microspheres were
poured till the time when upper tip of the pile surface touched
the lower tip of the funnel. The tan-1 of the height of the pile /
radius of its base gave the angle of repose.
Microspheres were poured gently through a glass funnel
into a graduated cylinder cut exactly to 10ml mark. Excess
microspheres were removed using a spatula and the weight of
the cylinder with pellets required for filling the cylinder volu-
me was calculated. The cylinder was then tapped from a height
of 2.0 cm until the time when there was no more decrease in
the volume. Bulk density (ρb) and tapped density (ρt) were
calculated. Hausner ratio (HR) and carr index (IC) were
calculated according to the two equations given below:
HR= ρt/ρb
IC = (ρt% ρb)/ρt
In vitro buoyancy
Microspheres (300mg) were spread over the surface of
a USP XXIV dissolution apparatus type II filled with 900 mL
of 0.1 N hydrochloric acid containing 0.02% tween 80. The
medium was agitated with a paddle rotating at 100 rpm for
12 h. The floating and the settled portions of microspheres
were recovered separately. The microspheres were dried and
weighed. Buoyancy percentage was calculated as the ratio of
the mass of the microspheres that remained floating and the
total mass of the microspheres (Srivastava et al., 2005).
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In vivo floating behaviour
Healthy beagle dogs weighing approximately 15 kg
was used to assess in vivo floating behaviour. Ethical
clearance for the handling of experimental animals was
obtained from the institutional animal ethical committee
(IAEC) constituted for the purpose. The animals were
fasted for 12 h and the first X-ray photographed to ensure
absence of radio opaque material in the stomach. The dogs
were made to swallow barium sulphate loaded cellulose
acetate microspheres with 100ml of water. During the
experiment dogs were not allowed to eat but water was
provided ad libitum. At predetermined time intervals the
radiograph of the abdomen was taken using an X-ray
machine (Medford).
Incorporation efficiency (IE)
To determine incorporation efficiency floating
microspheres were dissolved in a minimal amount of
dichloromethane and the drug was extracted into a suitable
aqueous media (0.1 N hydrochloric acid) by evaporating
dichloromethane. The solution was filtered through 0.45 m
membrane, diluted suitably and analyzed for drug content
spectrophotometrically at 278 nm using 0.1 N hydrochloric
acid as blank.
In vitro drug release studies
The drug release was studied using a USP 24 dissolution
apparatus type I (Veego Scientific, Mumbai) at 100 rpm in
0.1N hydrochloric acid as dissolution medium (900 mL)
maintained at 37±1°C. A sample (10 mL) of the solution was
withdrawn from the dissolution apparatus hourly and the
samples were replaced with fresh dissolution medium. The
samples were filtered through a 0.45 µ membrane filter and
diluted to a suitable concentration with 0.1 N hydrochloric
acid. Absorbance of these solutions was measured at 278 nm
using a Thermospectronic-1 UV/Vis double-beam spectro-
photometer. Cumulative percentage drug release was
calculated using an equation obtained from a standard curve.
RESULTS AND DISCUSSION
The floating microspheres of verapamil hydrochloride
were prepared by solvent diffusion-evaporation method. The
results of the physico-chemical characterization are shown
in Table I. The prepared floating microspheres were found to
be discrete, spherical and free flowing. The mean arithmetic
diameter varied between 251.80 to 350.75 μm; eudragit
S100 microspheres representing the least size and cellulose
acetate microspheres the largest size. Surface morphology
characteristics were studied using SEM (Figure 1). SEM
indicated that the prepared microspheres are spherical with
smooth surface; distinct pores are evident on the surface of
microspheres, which will be responsible for the release. The
photomicrographs also showed presence of loose crystals of
drug on the surface of few microspheres.
Angle of repose, hausner ratio, and carr index were
determined to predict flowability. A higher Hausner ratio
indicates greater cohesion between particles while a high
Carr index is indicative of the tendency to form bridges.
The prepared microspheres exhibited good flow properties
and can be arranged as: F1 > F3 > F2. The percentage yield
of floating microspheres was found to be 68.90, 63.60 and
70.51% for F1, F2 and F3 respectively. Percentage
incorporation efficiency was in the range of 64.31 % to
84.62%, cellulose acetate microspheres entrapped
maximum amount of the drug.
To assess the floating properties, the microspheres
were placed in 0.1N hydrochloric acid containing
surfactant tween 80 (0.02% v/v), to simulate gastric
conditions. The use of tween 80 was to account for the
wetting effect of the natural surface-active agents in the
GIT. The microspheres floated for prolonged time over the
surface of the dissolution medium without any apparent
gelation. Buoyancy percentage of the microspheres was in
the range of 46.19 to 69.59% at the end of 12 h. The nature
of the polymer influenced the floating behaviour of the
microspheres. The in vivo floating behaviour of cellulose
acetate microspheres loaded with barium sulphate was
investigated by radiographic images (X-ray photographs)
of dog’s stomach at periodic time intervals. To make the
TABLE I - Characterization of verapamil hydrochloride floating microspheres
Code Mean particle Angle of repose Hausner ratio Carr index Buoyancy Incorporation
size (μm) (θ) (HR) (IC) (%) efficiency (%)
F1 350.75 ± 5.30 24.42º ± 0.03 1.152 ± 0.045 0.141 ± 0.017 69.92 ± 1.27 84.62 ± 4.05
F2 307.85 ± 9.63 29.46º ± 0.28 1.180 ± 0.051 0.153 ± 0.010 46.19 ± 1.62 64.31 ± 3.61
F3 251.80 ± 7.27 28.29º ± 0.11 1.165 ± 0.022 0.149 ± 0.015 60.04 ± 1.41 72.29 ± 1.07
Results are expressed as Mean ± S.D. (n=5).
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microspheres X-ray opaque barium sulphate was
incorporated into the microspheres. The amount of X-ray
opaque material in these microspheres was sufficient to
ensure visibility by X-ray but at the same time the amount
of barium sulphate (10mg per g of microspheres) was low
enough to enable the microspheres to float. The duration of
floating in vitro was more than 8 h. The microspheres did
not adhere to the gastric mucous and floated on the gastric
fluid for about 3.2 ±0.05 h (Figure 2).
The drug release from floating microspheres was
found to be 95.52, 83.51 and 72.76% at the end of 12 h for
F1, F2 and F3 respectively (Figure 3). The data obtained
from in vitro dissolution studies were fitted to zero-order,
first-order and Korsemeyer-Peppas equations (Table II).
The zero-order plots were found to be fairly linear as
indicated by their high regression values of 0.989, 0.981
and 0.985 for F1, F2 and F3 respectively. To confirm the
exact mechanism of drug release, the data were fitted
according to Korsemeyer-Peppas equation (Korsemeyer et
al., 1983). Korsmeyer et al.(1983) used a simple empirical
equation to describe general solute release behaviour from
controlled release polymer matrices:
mt/mT = k tn
TABLE II - Kinetics of in vitro release from floating
microspheres of verapamil hydrochloride
Code Zero- First- Korsemeyer-
order order Peppas
k0 (mg.h
-1) R2 k1 (h
-1) R2 n R2
F1 8.003 0.989 -0.224 0.860 0.876 0.994
F2 7.034 0.981 -0.128 0.856 0.830 0.987
F3 6.269 0.985 -0.119 0.875 0.714 0.990
FIGURE 1 - SEM photomicrographs of floating microspheres of verapamil hydrochloride.
FIGURE 3 - In vitro release profile of verapamil
hydrochloride microspheres (n=5).
FIGURE 2 - In vivo floating behaviour of cellulose acetate
microspheres.
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where mt/mT is fraction of drug released, k is kinetic
constant, t is release time and n is the diffusional exponent
for drug release. Peppas stated that the above equation
could adequately describe the release of solutes from slabs,
spheres, cylinders and discs, regardless of the release
mechanism. The value of ‘n’ gives an indication of the
release mechanism; when n = 1, the release rate is
independent of time (zero-order) (case II transport), n = 0.5
for Fickian diffusion and when 0.5 < n <1.0, diffusion and
non-Fickian transport are implicated. Lastly, when n > 1.0
super case II transport is apparent. ’n’ is the slope value of
log mt/mT versus log time curve.
Regression analysis was performed and regression
values ‘R2’ were 0.990 to 0.994 for different formulations.
Slope values (0.5<n<1.0) suggest that the release of
verapamil hydrochloride from floating microspheres
followed non-Fickian diffusion mechanism. There is
significant difference in the release rate from formulations
prepared from different polymers (p<0.01). The type of
polymer significantly influenced the drug release rate, in the
order: Cellulose acetate > Acrycoat S100 > Eudragit S100.
CONCLUSIONS
Floating microspheres of verapamil hydrochloride
were prepared by a solvent diffusion-evaporation method.
The nature of polymer influenced the physical
characteristics as well as floating behaviour of the
microspheres. In vitro buoyancy and in vivo studies
confirmed the excellent floating properties of cellulose
acetate microspheres. The drug release was sufficiently
sustained and non-Fickian transport of the drug from
floating microspheres was confirmed. Hence the floating
microspheres of verapamil hydrochloride prepared with
cellulose acetate, may provide a convenient dosage form for
achieving best performance regarding flow, release and
floating properties. Further, their potential to improve
verapamil hydrochloride bioavailability in humans need to
be investigated in further studies.
RESUMO
Desenvolvimento e avaliação de microesferas flutuan-
tes de cloridrato de verapamil
O presente estudo envolve a preparação e a avaliação de
microesferas flutuantes de cloridrato de verapamil para o
melhoramento da biodisponibilidade do fármaco por meio
do prolongamento do tempo de residência gástrica. Prepa-
raram-se, por meio do método de difusão-evaporação de
solvente, microesferas de acetato de celulose, acrycoat
S100 e eudragit S100 carregadas com cloridrato de
verapamil. As microesferas apresentaram superfícies regu-
lares, com propriedades de fluxo livre e de bom
empacotamento. O rendimento das microesferas foi supe-
rior a 70,51% e as microesferas de acetato de celulose
captaram a quantidade máxima do fármaco. Microscopia
eletrônica de varredura confirmou as cavidades em suas
estruturas, com tamanhos na faixa de 251,80 a 350,75 μm.
As microesferas preparadas apresentaram liberação pro-
longada do fármaco e permaneceram flutuantes por mais
que 12 h. Imagens radiográficas do estômago de cão reve-
laram que as esferas de acetato de celulose carregadas com
sulfato de bário flutuaram no fluido gástrico por, aproxima-
damente, 3,2 h. Estudos de liberação in vitro demonstraram
difusão não-Fickiana dos fármacos das microesferas.
UNITERMS: Cloridrato de verapamil. Microesferas flu-
tuantes.
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